An exploratory clinical study of β-glucan combined with camrelizumab and SOX chemotherapy as first-line treatment for advanced gastric adenocarcinoma
一项探索性临床研究，旨在评估β-葡聚糖联合卡瑞利珠单抗和SOX化疗作为晚期胃腺癌一线治疗方案的疗效。
期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2024.1448485
Chu, Yunqian; He, Xuan; Xue, Ya; Jiang, Hua; Zhu, Chan; Qi, Chunjian; Zhang, Xing; Chen, Dongsheng; Dai, Hanjue; Xian, Qingying; Zhu, Wenyu
